Click image to view original image
PharmaLegacy Laboratories (Shanghai) Co., Ltd is specialized in Business services,Medical service,Medical insurance since established in 10 years ago.So far,our company has established its branch companies in major cities throughout the country.Formed in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China as the center, the radiation sales system and service network.Details:Immunotherapeutics fight cancer by taking advantage of a patient's own immune system, therefore, preclinical research into new therapies requires appropriate models with fully functional immunity. Syngeneic mouse model (allografts derived from immortalized mouse cancer cell lines which originated from the same inbred strain of mice) provide a valuable system for assessing new single agent, combination immunotherapies, or combination radiotherapy within mice with fully competent immunity. Pharmalegacy provides a panel of well validated syngeneic mouse models for preclinical immunotherapy research, used to interrogating novel immune-oncology treatments via activating the mouse immune system. We have model types include subcutaneous, orthotopic and metastatic. Our suite of syngeneic mouse model includes 22 models covering 14 cancer types and more on going, which validated with anti-PD-1, PD-L1 and anti-CTLA-4 antibodies
Adhering to the Sincere service, the pursuit of perfection spirit of enterprise, PharmaLegacy bases on long-term development, technology as the core, market-oriented, and constantly open up new areas, undertaking to provide fast, high-quality service for the vast numbers of users. For further information about PharmaLegacySyngeneic mouse model, please visit our official website: www.pharmalegacy.com.
